The Prostate Working Group is led by Dr. Dan Spratt, Dr. Bob Dess, and Dr. Jean Moran. The pilot initiative launched in July 2020 with plans to expand to the larger Michigan Radiation Oncology Quality Consortium in early 2021. The Prostate Group is working to minimize overutilization of unnecessary resources in localized prostate to advance value-based care.
Areas of Current & Ongoing Focus:
- Increase usage of active surveillance in patients with low risk disease
- Increase usage of guide concordant, cost effective radiation forms of radiation
- Decrease unnecessary hormone therapy administration and pelvic lymph node radiation
- Appropriate usage of staging scans